Founders Capital Management - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 60 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
Founders Capital Management ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,540
+289.6%
2,0000.0%0.00%
Q2 2023$652
+65100.0%
2,0000.0%0.00%
-100.0%
Q1 2023$10.0%2,0000.0%0.00%0.0%
Q4 2022$1
-100.0%
2,000
-33.3%
0.00%
-50.0%
Q3 2022$2,000
-33.3%
3,0000.0%0.00%0.0%
Q2 2022$3,000
-66.7%
3,0000.0%0.00%
-66.7%
Q1 2022$9,0000.0%3,0000.0%0.01%0.0%
Q4 2021$9,000
-30.8%
3,0000.0%0.01%
-33.3%
Q3 2021$13,000
-27.8%
3,000
+50.0%
0.01%
-30.8%
Q4 2020$18,0000.0%2,0000.0%0.01%
-31.6%
Q1 2020$18,000
+200.0%
2,000
+100.0%
0.02%
+280.0%
Q4 2019$6,000
-25.0%
1,0000.0%0.01%
-16.7%
Q3 2019$8,000
-42.9%
1,0000.0%0.01%
-50.0%
Q2 2019$14,000
+180.0%
1,0000.0%0.01%
+140.0%
Q1 2019$5,000
+66.7%
1,0000.0%0.01%
+66.7%
Q4 2018$3,000
-62.5%
1,0000.0%0.00%
-57.1%
Q3 2018$8,0001,0000.01%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Beryl Capital Management LLC 4,898,927$6,246,1320.70%
Yakira Capital Management, Inc. 620,019$790,5240.22%
Crystalline Management Inc. 230,817$294,2920.21%
DELTEC ASSET MANAGEMENT LLC 475,000$605,6250.14%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 2,283,979$2,912,0730.12%
PenderFund Capital Management Ltd. 123,444$2130.06%
FIFTH LANE CAPITAL, LP 100,000$127,0000.04%
CSS LLC/IL 476,831$607,9600.04%
Penserra Capital Management LLC 220,858$2800.01%
King Wealth Management Group 16,000$200.00%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders